SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-024033
Filing Date
2019-05-07
Accepted
2019-05-07 07:05:23
Documents
8
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv520696_6k.htm 6-K 167153
2 EXHIBIT 99.1 tv520696_ex99-1.htm EX-99.1 91144
3 GRAPHIC image_001.jpg GRAPHIC 14399
4 GRAPHIC image_002.jpg GRAPHIC 4647
5 GRAPHIC image_003.jpg GRAPHIC 4658
6 GRAPHIC image_004.jpg GRAPHIC 4681
7 GRAPHIC image_005.jpg GRAPHIC 4687
8 GRAPHIC image_006.jpg GRAPHIC 4686
  Complete submission text file 0001144204-19-024033.txt   312135
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 19801182
SIC: 2834 Pharmaceutical Preparations